JUN 06, 2022 10:30 AM PDT

Weight loss Surgery Reduces Cancer Risk and Cancer Deaths

WRITTEN BY: Annie Lennon

Weight loss achieved via bariatric surgery among adults with obesity is linked to a lower risk of developing cancer and cancer-related death compared to adults who do not undergo surgery. The corresponding study was published in JAMA

"According to the American Cancer Society, obesity is second only to tobacco as a preventable cause of cancer in the United States," said the study's senior author, Steven Nissen, M.D., Chief Academic Officer of the Heart, Vascular and Thoracic Institute, "This study provides the best possible evidence on the value of intentional weight loss to reduce cancer risk and mortality."

Around 43% of American adults live with obesity, according to the Centers for Disease Control and Prevention (CDC). Obesity is a significant risk factor for various cancer types, including colorectal, prostate, and renal. Currently, the most effective treatment option for obesity is bariatric surgery, which involves making changes to the digestive system to facilitate weight loss. 

In the current study, researchers analyzed health data from 5053 patients with obesity who underwent bariatric surgery and 25 265 matched patients in a nonsurgical group. 

After ten years, the researchers noted that 2.8% of the patients in the surgical group, and 4.9% of those in the nonsurgical group, developed obesity-associated cancer. These findings, noted the researchers, suggest that bariatric surgery is linked to a 32% lower risk of developing cancer.

Meanwhile, after 10 years, 0.8% of those in the surgery group died from cancer, while the same figure stood at 1.4% of those in the nonsurgical group. The researchers noted these findings mean that bariatric surgery is linked to a 48% lower risk of dying from cancer. 

"Based on the magnitude of benefit shown in our study, weight loss surgery can be considered in addition to other interventions that can help prevent cancer and reduce mortality," said Jame Abraham, M.D., chairman of the Hematology and Medical Oncology Department at Cleveland Clinic.

"Further research needs to be done to understand the underlying mechanisms responsible for reduced cancer risk following bariatric surgery," he added. 

 

Sources: JAMA, Science Daily

 

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 20, 2022
Immunology
Rare Soil Microbe Shows Promise as New Antibiotic
APR 20, 2022
Rare Soil Microbe Shows Promise as New Antibiotic
  Antibiotic resistance has increased the demand for new antibiotic treatments. Now, researchers have found that a ...
MAY 17, 2022
Cancer
Looking for an Easier Way to Scale-up Your Benchtop Cell Cultures?
MAY 17, 2022
Looking for an Easier Way to Scale-up Your Benchtop Cell Cultures?
Much has been written about scaling up cell culture for bioprocessing and other applications that require a very high de ...
JUN 21, 2022
Cell & Molecular Biology
From sample collection straight to RT-qPCR
JUN 21, 2022
From sample collection straight to RT-qPCR
Skip the nucleic acid purification step in your cancer detection workflow. Learn more about how Thermo Fisher Scientific ...
JUN 04, 2022
Drug Discovery & Development
Antibiotics Reduce Motivation to Exercise in Mice
JUN 04, 2022
Antibiotics Reduce Motivation to Exercise in Mice
Antibiotics may decrease athletes' motivation and endurance via effects on the microbiome. The corresponding study w ...
JUN 15, 2022
Plants & Animals
Using Mosquito Spit to Develop Vaccines for Zika, Yellow Fever, Dengue
JUN 15, 2022
Using Mosquito Spit to Develop Vaccines for Zika, Yellow Fever, Dengue
Mosquitoes, specifically, the Aedes mosquito, can carry and transmit deadly virsues like the Zika virus and the viruses ...
JUN 20, 2022
Health & Medicine
In a Small Study, Experimental Immunotherapy Drug for Rectal Cancer has a High Success Rate
JUN 20, 2022
In a Small Study, Experimental Immunotherapy Drug for Rectal Cancer has a High Success Rate
The New England Journal of Medicine published results from a small study by researchers at New York’s Memorial Slo ...
Loading Comments...